New biomarker predicts immunotherapy response in gastrointestinal cancers Despite significant progress in treating gastrointestinal (GI) cancers through surgical resection, chemotherapy, radiotherapy, and targeted therapy, the objective response rate (ORR) for immune checkpoint inhibitor (ICI) therapy remains low.
https://www.news-medical.net/n....ews/20240430/New-bio